| 100807-7 |
Vasopressin^4th specimen post XXX challenge |
SCnc |
Plas |
Pt |
Qn |
|
|
ACTIVE |
Vasopressin [Moles/volume] in Plasma --4th specimen post XXX challenge |
|
ADD |
DefinitionDescription |
|
|
pmol/L |
|
|
|
|
|
|
CHAL |
|
100807-7 |
|
|
|
|
Both |
|
|
|
0 |
Vasopressin sp4 p chal Plas-sCnc |
|
|
|
N |
|
ADH; Adiuretin; After; Antidiuretic hormone; Arginine vasopressin hormone; AVH; CHEMISTRY.CHALLENGE TESTING; Level; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; sp4; sp4 p chal; Spec; Substance concentration; VP |
2.73 |
2.73 |
|
|
|
|
|
|
|
pmol/L |
|
|
|
0 |
| 100808-5 |
Vasopressin^5th specimen post XXX challenge |
SCnc |
Plas |
Pt |
Qn |
|
|
ACTIVE |
Vasopressin [Moles/volume] in Plasma --5th specimen post XXX challenge |
|
ADD |
DefinitionDescription |
|
|
pmol/L |
|
|
|
|
|
|
CHAL |
|
100808-5 |
|
|
|
|
Both |
|
|
|
0 |
Vasopressin sp5 p chal Plas-sCnc |
|
|
|
N |
|
ADH; Adiuretin; After; Antidiuretic hormone; Arginine vasopressin hormone; AVH; CHEMISTRY.CHALLENGE TESTING; Level; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; sp5; sp5 p chal; Spec; Substance concentration; VP |
2.73 |
2.73 |
|
|
|
|
|
|
|
pmol/L |
|
|
|
0 |
| 100809-3 |
Vasopressin^6th specimen post XXX challenge |
SCnc |
Plas |
Pt |
Qn |
|
|
ACTIVE |
Vasopressin [Moles/volume] in Plasma --6th specimen post XXX challenge |
|
ADD |
DefinitionDescription |
|
|
pmol/L |
|
|
|
|
|
|
CHAL |
|
100809-3 |
|
|
|
|
Both |
|
|
|
0 |
Vasopressin sp6 p chal Plas-sCnc |
|
|
|
N |
|
ADH; Adiuretin; After; Antidiuretic hormone; Arginine vasopressin hormone; AVH; CHEMISTRY.CHALLENGE TESTING; Level; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; sp6; sp6 p chal; Spec; Substance concentration; VP |
2.73 |
2.73 |
|
|
|
|
|
|
|
pmol/L |
|
|
|
0 |
| 10081-8 |
S' wave duration.lead V6 |
Time |
Heart |
Pt |
Qn |
EKG |
|
ACTIVE |
S' wave duration in lead V6 |
|
MIN |
DefinitionDescription |
|
|
s |
|
|
|
|
|
|
EKG.MEAS |
|
10081-8 |
|
EKG |
|
|
Observation |
|
|
|
0 |
S' wave dur L-V6 |
|
|
|
Y |
|
Cardiac; Cardio; Cardiology; Durat; ECG; EKG.MEASUREMENTS; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; QNT; Quan; Quant; Quantitative; Random; S prime; S' wave dur L-V6; S wave dur L-V6 |
2.48 |
1.0i |
|
|
|
|
|
|
|
s |
|
|
|
0 |
| 100810-1 |
Vasopressin^7th specimen post XXX challenge |
SCnc |
Plas |
Pt |
Qn |
|
|
ACTIVE |
Vasopressin [Moles/volume] in Plasma --7th specimen post XXX challenge |
|
ADD |
DefinitionDescription |
|
|
pmol/L |
|
|
|
|
|
|
CHAL |
|
100810-1 |
|
|
|
|
Both |
|
|
|
0 |
Vasopressin sp7 p chal Plas-sCnc |
|
|
|
N |
|
^7th spec pst XXX chal; ADH; Adiuretin; After; Antidiuretic hormone; Arginine vasopressin hormone; AVH; CHEMISTRY.CHALLENGE TESTING; Level; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; sp7; sp7 p chal; Spec; Substance concentration; VP |
2.73 |
2.73 |
|
|
|
|
|
|
|
pmol/L |
|
|
|
0 |
| 100811-9 |
Vasopressin^8th specimen post XXX challenge |
SCnc |
Plas |
Pt |
Qn |
|
|
ACTIVE |
Vasopressin [Moles/volume] in Plasma --8th specimen post XXX challenge |
|
ADD |
DefinitionDescription |
|
|
pmol/L |
|
|
|
|
|
|
CHAL |
|
100811-9 |
|
|
|
|
Both |
|
|
|
0 |
Vasopressin sp8 p chal Plas-sCnc |
|
|
|
N |
|
ADH; Adiuretin; After; Antidiuretic hormone; Arginine vasopressin hormone; AVH; CHEMISTRY.CHALLENGE TESTING; Level; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; sp8; sp8 p chal; Spec; Substance concentration; VP |
2.73 |
2.73 |
|
|
|
|
|
|
|
pmol/L |
|
|
|
0 |
| 100812-7 |
Vasopressin^9th specimen post XXX challenge |
SCnc |
Plas |
Pt |
Qn |
|
|
ACTIVE |
Vasopressin [Moles/volume] in Plasma --9th specimen post XXX challenge |
|
ADD |
DefinitionDescription |
|
|
pmol/L |
|
|
|
|
|
|
CHAL |
|
100812-7 |
|
|
|
|
Both |
|
|
|
0 |
Vasopressin sp9 p chal Plas-sCnc |
|
|
|
N |
|
ADH; Adiuretin; After; Antidiuretic hormone; Arginine vasopressin hormone; AVH; CHEMISTRY.CHALLENGE TESTING; Level; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; sp9; sp9 p chal; Spec; Substance concentration; VP |
2.73 |
2.73 |
|
|
|
|
|
|
|
pmol/L |
|
|
|
0 |
| 100813-5 |
Vasopressin^10th specimen post XXX challenge |
SCnc |
Plas |
Pt |
Qn |
|
|
ACTIVE |
Vasopressin [Moles/volume] in Plasma --10th specimen post XXX challenge |
|
ADD |
DefinitionDescription |
|
|
pmol/L |
|
|
|
|
|
|
CHAL |
|
100813-5 |
|
|
|
|
Both |
|
|
|
0 |
Vasopressin sp10 p chal Plas-sCnc |
|
|
|
N |
|
ADH; Adiuretin; After; Antidiuretic hormone; Arginine vasopressin hormone; AVH; CHEMISTRY.CHALLENGE TESTING; Level; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; sp10; sp10 p chal; Spec; Substance concentration; VP |
2.73 |
2.73 |
|
|
|
|
|
|
|
pmol/L |
|
|
|
0 |
| 100814-3 |
Vasopressin^11th specimen post XXX challenge |
SCnc |
Plas |
Pt |
Qn |
|
|
ACTIVE |
Vasopressin [Moles/volume] in Plasma --11th specimen post XXX challenge |
|
ADD |
DefinitionDescription |
|
|
pmol/L |
|
|
|
|
|
|
CHAL |
|
100814-3 |
|
|
|
|
Both |
|
|
|
0 |
Vasopressin sp11 p chal Plas-sCnc |
|
|
|
N |
|
ADH; Adiuretin; After; Antidiuretic hormone; Arginine vasopressin hormone; AVH; CHEMISTRY.CHALLENGE TESTING; Level; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; sp11; sp11 p chal; Spec; Substance concentration; VP |
2.73 |
2.73 |
|
|
|
|
|
|
|
pmol/L |
|
|
|
0 |
| 100815-0 |
Vasopressin^12th specimen post XXX challenge |
SCnc |
Plas |
Pt |
Qn |
|
|
ACTIVE |
Vasopressin [Moles/volume] in Plasma --12th specimen post XXX challenge |
|
ADD |
DefinitionDescription |
|
|
pmol/L |
|
|
|
|
|
|
CHAL |
|
100815-0 |
|
|
|
|
Both |
|
|
|
0 |
Vasopressin sp12 p chal Plas-sCnc |
|
|
|
N |
|
ADH; Adiuretin; After; Antidiuretic hormone; Arginine vasopressin hormone; AVH; CHEMISTRY.CHALLENGE TESTING; Level; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; sp12; sp12 p chal; Spec; Substance concentration; VP |
2.73 |
2.73 |
|
|
|
|
|
|
|
pmol/L |
|
|
|
0 |
| 100816-8 |
Glucagon^6th specimen post XXX challenge |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Glucagon [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |
|
ADD |
DefinitionDescription |
|
|
ng/L |
|
|
|
|
|
|
CHAL |
|
100816-8 |
|
|
|
|
Both |
|
|
|
0 |
Glucagon sp6 p chal SerPl-mCnc |
|
|
|
N |
|
After; CHEMISTRY.CHALLENGE TESTING; HGF; Hyperglycemic factor; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp6; sp6 p chal; Spec; SR |
2.73 |
2.73 |
|
|
|
|
|
|
|
ng/L |
|
|
|
0 |
| 100817-6 |
Glucagon^7th specimen post XXX challenge |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Glucagon [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge |
|
ADD |
DefinitionDescription |
|
|
ng/L |
|
|
|
|
|
|
CHAL |
|
100817-6 |
|
|
|
|
Both |
|
|
|
0 |
Glucagon sp7 p chal SerPl-mCnc |
|
|
|
N |
|
^7th spec pst XXX chal; After; CHEMISTRY.CHALLENGE TESTING; HGF; Hyperglycemic factor; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp7; sp7 p chal; Spec; SR |
2.73 |
2.73 |
|
|
|
|
|
|
|
ng/L |
|
|
|
0 |
| 100818-4 |
Renin^1st specimen post XXX challenge |
MCnc |
Plas |
Pt |
Qn |
|
|
ACTIVE |
Renin [Mass/volume] in Plasma --1st specimen post XXX challenge |
|
ADD |
DefinitionDescription |
|
|
pg/mL |
|
|
|
|
|
|
CHAL |
|
100818-4 |
|
|
|
|
Both |
|
|
|
0 |
Renin sp1 p chal Plas-mCnc |
|
|
|
N |
|
Acute specimen; After; Angiotensin forming enzyme; Angiotensinogenase; CHEMISTRY.CHALLENGE TESTING; Direct renin; DRC; First; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; Pre immunization; PST; QNT; Quan; Quant; Quantitative; Random; sp1; sp1 p chal; Spec |
2.73 |
2.73 |
|
|
|
|
|
|
|
pg/mL |
|
|
|
0 |
| 100819-2 |
Renin^2nd specimen post XXX challenge |
MCnc |
Plas |
Pt |
Qn |
|
|
ACTIVE |
Renin [Mass/volume] in Plasma --2nd specimen post XXX challenge |
|
ADD |
DefinitionDescription |
|
|
pg/mL |
|
|
|
|
|
|
CHAL |
|
100819-2 |
|
|
|
|
Both |
|
|
|
0 |
Renin sp2 p chal Plas-mCnc |
|
|
|
N |
|
After; Angiotensin forming enzyme; Angiotensinogenase; CHEMISTRY.CHALLENGE TESTING; Convalescent; Direct renin; DRC; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; Post immunization; PST; QNT; Quan; Quant; Quantitative; Random; Second; sp2; sp2 p chal; Spec |
2.73 |
2.73 |
|
|
|
|
|
|
|
pg/mL |
|
|
|
0 |
| 10082-6 |
ST initial amplitude 6 ms.lead AVF |
Elpot |
Heart |
Pt |
Qn |
EKG |
|
ACTIVE |
ST initial amplitude 6 ms in lead AVF |
|
MIN |
DefinitionDescription |
|
|
mV |
|
|
|
|
|
|
EKG.MEAS |
|
10082-6 |
|
EKG |
|
|
Observation |
|
|
|
0 |
ST I-Amp 6ms L-AVF |
|
|
|
Y |
|
Cardiac; Cardio; Cardiology; ECG; EKG.MEASUREMENTS; Electrical potential; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; QNT; Quan; Quant; Quantitative; Random; ST I-Amp 6ms L-AVF; Voltage |
2.48 |
1.0i |
|
|
|
|
|
|
|
mV |
|
|
|
0 |
| 100820-0 |
Renin^3rd specimen post XXX challenge |
MCnc |
Plas |
Pt |
Qn |
|
|
ACTIVE |
Renin [Mass/volume] in Plasma --3rd specimen post XXX challenge |
|
ADD |
DefinitionDescription |
|
|
pg/mL |
|
|
|
|
|
|
CHAL |
|
100820-0 |
|
|
|
|
Both |
|
|
|
0 |
Renin sp3 p chal Plas-mCnc |
|
|
|
N |
|
After; Angiotensin forming enzyme; Angiotensinogenase; CHEMISTRY.CHALLENGE TESTING; Direct renin; DRC; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; sp3; sp3 p chal; Spec |
2.73 |
2.73 |
|
|
|
|
|
|
|
pg/mL |
|
|
|
0 |
| 100821-8 |
POLST panel |
- |
^Patient |
Pt |
- |
POLST |
|
ACTIVE |
National POLST form: portable medical order panel |
|
PANEL |
DefinitionDescription |
|
|
|
|
�© 2019 National POLST. The National POLST Form may only be used for non-commercial, personal purposes. Commercial or facility use requires a license from National POLST or an authorized reseller. For use options or to discuss permissions, please visit: https://polst.org/terms/. |
|
|
|
|
PANEL.CLIN |
|
100821-8 |
|
POLST |
|
|
Order |
|
|
|
0 |
POLST panel |
|
|
|
N |
|
CLIN; Pan; PANEL.CLINICAL; Panl; Pnl; Point in time; Random |
2.74 |
2.73 |
|
Panel |
|
|
�© 2019 National POLST. The National POLST Form may only be used for non-commercial, personal purposes. Commercial or facility use requires a license from National POLST or an authorized reseller. For use options or to discuss permissions, please visit: https://polst.org/terms/. |
|
|
|
|
|
|
0 |
| 100822-6 |
Cardiopulmonary resuscitation orders |
Find |
^Patient |
Pt |
Ord |
POLST |
|
ACTIVE |
Cardiopulmonary resuscitation orders |
|
ADD |
DefinitionDescription |
|
|
|
|
�© 2019 National POLST. The National POLST Form may only be used for non-commercial, personal purposes. Commercial or facility use requires a license from National POLST or an authorized reseller. For use options or to discuss permissions, please visit: https://polst.org/terms/. |
|
|
|
|
CLIN |
|
100822-6 |
|
POLST |
|
|
Both |
|
|
|
0 |
CPR orders |
|
|
|
N |
|
CLIN; CPR; CPR orders; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen |
2.73 |
2.73 |
|
|
|
|
�© 2019 National POLST. The National POLST Form may only be used for non-commercial, personal purposes. Commercial or facility use requires a license from National POLST or an authorized reseller. For use options or to discuss permissions, please visit: https://polst.org/terms/. |
|
|
|
|
|
|
0 |
| 100823-4 |
Initial portable medical treatment orders |
Find |
^Patient |
Pt |
Nom |
POLST |
|
ACTIVE |
Initial portable medical treatment orders |
|
ADD |
DefinitionDescription |
|
|
|
|
�© 2019 National POLST. The National POLST Form may only be used for non-commercial, personal purposes. Commercial or facility use requires a license from National POLST or an authorized reseller. For use options or to discuss permissions, please visit: https://polst.org/terms/. |
|
|
|
|
CLIN |
|
100823-4 |
|
POLST |
|
|
Both |
|
|
|
0 |
Initial POLST orders |
|
|
|
N |
|
CLIN; Finding; Findings; Initial POLST orders; Nominal; Point in time; Random; SDOH; Tx |
2.73 |
2.73 |
|
|
|
|
�© 2019 National POLST. The National POLST Form may only be used for non-commercial, personal purposes. Commercial or facility use requires a license from National POLST or an authorized reseller. For use options or to discuss permissions, please visit: https://polst.org/terms/. |
|
|
|
|
|
|
0 |
| 100824-2 |
Additional portable medical orders or instructions |
Find |
^Patient |
Pt |
Nar |
POLST |
|
ACTIVE |
Additional portable medical orders or instructions |
|
ADD |
DefinitionDescription |
|
|
|
|
�© 2019 National POLST. The National POLST Form may only be used for non-commercial, personal purposes. Commercial or facility use requires a license from National POLST or an authorized reseller. For use options or to discuss permissions, please visit: https://polst.org/terms/. |
|
|
|
|
CLIN |
|
100824-2 |
|
POLST |
|
|
Both |
|
|
|
0 |
Add portable medical orders instructions |
|
|
|
N |
|
Add; Add portable medical orders instructions; CLIN; Finding; Findings; Narrative; Point in time; Random; Report |
2.73 |
2.73 |
|
|
|
|
�© 2019 National POLST. The National POLST Form may only be used for non-commercial, personal purposes. Commercial or facility use requires a license from National POLST or an authorized reseller. For use options or to discuss permissions, please visit: https://polst.org/terms/. |
|
|
|
|
|
|
0 |
| 100825-9 |
Medically assisted nutrition orders |
Find |
^Patient |
Pt |
Nom |
POLST |
|
ACTIVE |
Medically assisted nutrition orders |
|
ADD |
DefinitionDescription |
|
|
|
|
�© 2019 National POLST. The National POLST Form may only be used for non-commercial, personal purposes. Commercial or facility use requires a license from National POLST or an authorized reseller. For use options or to discuss permissions, please visit: https://polst.org/terms/. |
|
|
|
|
CLIN |
|
100825-9 |
|
POLST |
|
|
Both |
|
|
|
0 |
Med assisted nutrition orders |
|
|
|
N |
|
CLIN; Finding; Findings; Med assisted nutrition orders; Nominal; Point in time; Random; SDOH |
2.73 |
2.73 |
|
|
|
|
�© 2019 National POLST. The National POLST Form may only be used for non-commercial, personal purposes. Commercial or facility use requires a license from National POLST or an authorized reseller. For use options or to discuss permissions, please visit: https://polst.org/terms/. |
|
|
|
|
|
|
0 |
| 100826-7 |
Portable medical order &or advance directive review |
Find |
^Patient |
Pt |
Nom |
POLST |
|
ACTIVE |
Portable medical order AndOr advance directive review |
|
ADD |
DefinitionDescription |
|
|
|
|
�© 2019 National POLST. The National POLST Form may only be used for non-commercial, personal purposes. Commercial or facility use requires a license from National POLST or an authorized reseller. For use options or to discuss permissions, please visit: https://polst.org/terms/. |
|
|
|
|
CLIN |
|
100826-7 |
|
POLST |
|
|
Both |
|
|
|
0 |
Portable medical order&or adv dir review |
|
|
|
N |
|
Advanced; CLIN; directives; Finding; Findings; Nominal; Point in time; Portable medical order&or adv dir review; Random |
2.73 |
2.73 |
|
|
|
|
�© 2019 National POLST. The National POLST Form may only be used for non-commercial, personal purposes. Commercial or facility use requires a license from National POLST or an authorized reseller. For use options or to discuss permissions, please visit: https://polst.org/terms/. |
|
|
|
|
|
|
0 |
| 100827-5 |
Portable medical order discussion participants |
Find |
^Patient |
Pt |
Nom |
POLST |
|
ACTIVE |
Portable medical order discussion participants |
|
ADD |
DefinitionDescription |
|
|
|
|
�© 2019 National POLST. The National POLST Form may only be used for non-commercial, personal purposes. Commercial or facility use requires a license from National POLST or an authorized reseller. For use options or to discuss permissions, please visit: https://polst.org/terms/. |
|
|
|
|
CLIN |
|
100827-5 |
|
POLST |
|
|
Both |
|
|
|
0 |
Portable med order discus participants |
|
|
|
N |
|
CLIN; Finding; Findings; Nominal; Point in time; Portable med order discus participants; Random |
2.73 |
2.73 |
|
|
|
|
�© 2019 National POLST. The National POLST Form may only be used for non-commercial, personal purposes. Commercial or facility use requires a license from National POLST or an authorized reseller. For use options or to discuss permissions, please visit: https://polst.org/terms/. |
|
|
|
|
|
|
0 |
| 100828-3 |
Portable medical order administrative information |
Find |
^Patient |
Pt |
Nar |
POLST |
|
ACTIVE |
Portable medical order administrative information |
|
ADD |
DefinitionDescription |
|
|
|
|
�© 2019 National POLST. The National POLST Form may only be used for non-commercial, personal purposes. Commercial or facility use requires a license from National POLST or an authorized reseller. For use options or to discuss permissions, please visit: https://polst.org/terms/. |
|
|
|
|
CLIN |
|
100828-3 |
|
POLST |
|
|
Both |
|
|
|
0 |
Portable medical order admin info |
|
|
|
N |
|
Admin info; CLIN; Finding; Findings; Narrative; Point in time; Portable medical order admin info; Random; Report |
2.73 |
2.73 |
|
|
|
|
�© 2019 National POLST. The National POLST Form may only be used for non-commercial, personal purposes. Commercial or facility use requires a license from National POLST or an authorized reseller. For use options or to discuss permissions, please visit: https://polst.org/terms/. |
|
|
|
|
|
|
0 |
| 100829-1 |
Renin^4th specimen post XXX challenge |
MCnc |
Plas |
Pt |
Qn |
|
|
ACTIVE |
Renin [Mass/volume] in Plasma --4th specimen post XXX challenge |
|
ADD |
DefinitionDescription |
|
|
pg/mL |
|
|
|
|
|
|
CHAL |
|
100829-1 |
|
|
|
|
Both |
|
|
|
0 |
Renin sp4 p chal Plas-mCnc |
|
|
|
N |
|
After; Angiotensin forming enzyme; Angiotensinogenase; CHEMISTRY.CHALLENGE TESTING; Direct renin; DRC; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; sp4; sp4 p chal; Spec |
2.73 |
2.73 |
|
|
|
|
|
|
|
pg/mL |
|
|
|
0 |